OBJECTIVE: To determine the predictors of incidence of metabolic syndrome (MetS) (Adult Treatment Panel III criteria) and to determine if longitudinal changes in specific MetS components differ by age or gender in participants who developed versus those who did not develop MetS. METHODS: A total of 506 men and 461 women (baseline age 52.4 +/- 17.5 years) from the Baltimore Longitudinal Study on Aging (BLSA) were followed longitudinally (at least two study visits), and censored when they developed the MetS or reported use of antihypertensive or lipid-lowering medications. RESULTS: After a follow-up period of 6 years, the incidence of the MetS was 25.5% in men and 14.8% in women. As many as 66% of men and 73% of women with one or two altered MetS components at baseline did not develop the MetS. Predictors of developing MetS were higher baseline abdominal obesity or triglycerides and lower high-density lipoprotein cholesterol (area under receiver-operated curve [AUC] = 0.84 in men, 0.88 in women). Addition of the rate of changes in MetS components over time slightly improved predictive accuracy (AUC = 0.94 in men, 0.92 in women). Men were more likely than women to have the MetS without obesity, whereas women were more likely than men to have the MetS without an altered glucose metabolism. CONCLUSIONS: The patterns of MetS components and the longitudinal changes that lead to the MetS are different in men and women. Interestingly, components with the highest prevalence prior to MetS development, such as elevated blood pressure, are not necessarily the stronger risk factors.
OBJECTIVE: To determine the predictors of incidence of metabolic syndrome (MetS) (Adult Treatment Panel III criteria) and to determine if longitudinal changes in specific MetS components differ by age or gender in participants who developed versus those who did not develop MetS. METHODS: A total of 506 men and 461 women (baseline age 52.4 +/- 17.5 years) from the Baltimore Longitudinal Study on Aging (BLSA) were followed longitudinally (at least two study visits), and censored when they developed the MetS or reported use of antihypertensive or lipid-lowering medications. RESULTS: After a follow-up period of 6 years, the incidence of the MetS was 25.5% in men and 14.8% in women. As many as 66% of men and 73% of women with one or two altered MetS components at baseline did not develop the MetS. Predictors of developing MetS were higher baseline abdominal obesity or triglycerides and lower high-density lipoprotein cholesterol (area under receiver-operated curve [AUC] = 0.84 in men, 0.88 in women). Addition of the rate of changes in MetS components over time slightly improved predictive accuracy (AUC = 0.94 in men, 0.92 in women). Men were more likely than women to have the MetS without obesity, whereas women were more likely than men to have the MetS without an altered glucose metabolism. CONCLUSIONS: The patterns of MetS components and the longitudinal changes that lead to the MetS are different in men and women. Interestingly, components with the highest prevalence prior to MetS development, such as elevated blood pressure, are not necessarily the stronger risk factors.
Authors: J Stevens; L E Chambless; H A Tyroler; W Rosamond; F J Nieto; P Schreiner; D W Jones; D Arnett Journal: Int J Obes Relat Metab Disord Date: 2002-01
Authors: M T Guagnano; E Ballone; V Colagrande; R Della Vecchia; M R Manigrasso; D Merlitti; G Riccioni; S Sensi Journal: Int J Obes Relat Metab Disord Date: 2001-09
Authors: ShanKuan Zhu; ZiMian Wang; Stanley Heshka; Moonseong Heo; Myles S Faith; Steven B Heymsfield Journal: Am J Clin Nutr Date: 2002-10 Impact factor: 7.045
Authors: Latha Palaniappan; Mercedes R Carnethon; Yun Wang; Anthony J G Hanley; Stephen P Fortmann; Stephen M Haffner; Lynne Wagenknecht Journal: Diabetes Care Date: 2004-03 Impact factor: 19.112
Authors: Lyndon J Joseph; Ronald L Prigeon; Jacob B Blumenthal; Alice S Ryan; Andrew P Goldberg Journal: J Gerontol A Biol Sci Med Sci Date: 2011-06-08 Impact factor: 6.053
Authors: Angelo Scuteri; Marco Orru'; Christopher H Morrell; Kirill Tarasov; David Schlessinger; Manuela Uda; Edward G Lakatta Journal: Atherosclerosis Date: 2011-12-14 Impact factor: 5.162
Authors: Angelo Scuteri; Marco Orru; Christopher Morrell; Maria Grazia Piras; Dennis Taub; David Schlessinger; Manuela Uda; Edward G Lakatta Journal: Atherosclerosis Date: 2010-12-30 Impact factor: 5.162
Authors: Antonio Terracciano; Angelina R Sutin; Yang An; Richard J O'Brien; Luigi Ferrucci; Alan B Zonderman; Susan M Resnick Journal: Alzheimers Dement Date: 2013-05-21 Impact factor: 21.566
Authors: Angelo Scuteri; Stephane Laurent; Francesco Cucca; John Cockcroft; Pedro Guimaraes Cunha; Leocadio Rodriguez Mañas; Francesco U Mattace Raso; Maria Lorenza Muiesan; Ligita Ryliškytė; Ernst Rietzschel; James Strait; Charalambos Vlachopoulos; Henry Völzke; Edward G Lakatta; Peter M Nilsson Journal: Eur J Prev Cardiol Date: 2014-03-19 Impact factor: 7.804